UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management

Frontiers in pharmacology, 2023-01, Vol.13, p.1088031

2023

Volltextzugriff (PDF)

CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults

Cancers, 2020-01, Vol.12 (2), p.303

2020

Volltextzugriff (PDF)

The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice

Frontiers in immunology, 2020-05, Vol.11, p.888

2020

Volltextzugriff (PDF)

Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation

Expert review of hematology, 2016-06, Vol.9 (6), p.585-596

2016

Volltextzugriff (PDF)

Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation

Cancers, 2024-02, Vol.16 (5), p.865

2024

Volltextzugriff (PDF)

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma

Haematologica (Roma), 2019-02, Vol.104 (2), p.380-391

2019

Volltextzugriff (PDF)

Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients

Frontiers in immunology, 2023-01, Vol.13, p.1058739-1058739

2023

Volltextzugriff (PDF)

Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity

Frontiers in immunology, 2023-01, Vol.13, p.1058126-1058126

2023

Volltextzugriff (PDF)

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia

Frontiers in oncology, 2022-11, Vol.12, p.1066285-1066285

2022

Volltextzugriff (PDF)

Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting

Bone marrow transplantation (Basingstoke), 2018-10, Vol.53 (10), p.1304-1310

2018

Volltextzugriff (PDF)

An update on the treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

Expert review of hematology, 2019-11, Vol.12 (11), p.937-945

2019

Volltextzugriff (PDF)

Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia

Clinical hematology international, 2019, Vol.1 (2), p.85-93

2019

Volltextzugriff (PDF)

Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft- versus -lymphoma effect

Haematologica (Roma), 2018-06, Vol.103 (6), p.e252-e255

2018

Volltextzugriff (PDF)

Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model

Cells (Basel, Switzerland), 2020-12, Vol.9 (12), p.2666

2020

Volltextzugriff (PDF)

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report

Journal of hematology and oncology, 2016-08, Vol.9 (1), p.67-67, Article 67

2016

Volltextzugriff (PDF)

Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation

Biology of blood and marrow transplantation, 2017-03, Vol.23 (3), p.388-397

2017

Volltextzugriff (PDF)

ISSUE HIGHLIGHTS ‐ July 2020

Cytometry. Part B, Clinical cytometry, 2020-07, Vol.98 (4), p.295-298

2020

Volltextzugriff (PDF)

Late-Onset Hepatic Veno-Occlusive Disease after Allografting: Report of Two Cases with Atypical Clinical Features Successfully Treated with Defibrotide

Mediterranean journal of hematology and infectious diseases, 2018, Vol.10 (1), p.e2018001-e2018001

2018

Volltextzugriff (PDF)

Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives

Frontiers in bioscience, 2019-06, Vol.24 (7), p.1284-1315, Article 4780

2019

Volltextzugriff (PDF)

Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost

British journal of haematology, 2024-03, Vol.204 (3), p.1109-1113

2024

Volltextzugriff (PDF)

Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)

Bone marrow transplantation (Basingstoke), 2022-10, Vol.57 (10), p.1556-1563

2022

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Bone marrow transplantation (Basingstoke), 2024-07, Vol.59 (7), p.983-990

2024

Volltextzugriff (PDF)

Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy

Neurological sciences, 2024-08, Vol.45 (8), p.4007-4014

2024

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Bone marrow transplantation (Basingstoke), 2023-09, Vol.58 (9), p.1033-1041

2023

Volltextzugriff (PDF)

Correction to: Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy

Neurological sciences, 2024-08, Vol.45 (8), p.4107-4107

2024

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(36)
Science & Technology
(36)
Humans
(22)
Hematology
(19)
Female
(10)
Immunology
(10)
Male
(10)
Middle Aged
(10)
Oncology
(10)
Leukemia
(9)
Transplantation
(9)
Adult
(8)
Aged
(8)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(8)
Stem Cell Transplantation
(8)
Hematopoietic Stem Cell Transplantation
(7)
Acute Myeloid Leukemia
(6)
Bone Marrow
(6)
Adolescent
(5)
Hematopoietic Stem Cells
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management

CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults

The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice

Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation

Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma

Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients

Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia

Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting

An update on the treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia

Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft- versus -lymphoma effect

Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report

Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation

ISSUE HIGHLIGHTS ‐ July 2020

Late-Onset Hepatic Veno-Occlusive Disease after Allografting: Report of Two Cases with Atypical Clinical Features Successfully Treated with Defibrotide

Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives

Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost

Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)

Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy

Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Correction to: Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy

Suchergebnisse filtern